GWS
INTS icon

Glassman Wealth Services’s Intensity Therapeutics INTS Stock Holding History

Glassman Wealth Services’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$1.71K – 973
2023
Q4 		$1.71K Hold
8
– – ﹤0.01% 1394
2023
Q3 		$794 Hold
8
– – ﹤0.01% 1620
2023
Q2 		$1.19K Buy
+8
New +$1.19K ﹤0.01% 1392

Other funds holding INTS

SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
BW
Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Glassman Wealth Services's INTS Position: Q1 2024 in Review

Glassman Wealth Services sold out of Intensity Therapeutics (INTS) in Q1 2024, closing a stake of 8 shares — an estimated $1.71K sold.

Glassman Wealth Services first reported a position in INTS in Q2 2023 and held it in 3 quarters. The position peaked at $1.71K in Q4 2023. 17 funds tracked by Wall St. Rank hold INTS as of Q1 2024.

  • Glassman Wealth Services reported no remaining Intensity Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 8 Intensity Therapeutics shares in Q1 2024, an estimated $1.71K.
  • Glassman Wealth Services first reported a position in Intensity Therapeutics in Q2 2023 and held it in 3 quarters.
  • Glassman Wealth Services's Intensity Therapeutics position peaked at $1.71K in Q4 2023.
  • 17 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.